TUCSON, Ariz.--(BUSINESS WIRE)--Research Corporation Technologies (RCT) announces that Gary M. Munsinger, Ph.D., resigned from its Board of Directors and all positions associated with RCT, effective May 15, 2018. Dr. Munsinger was a founding Director of RCT in 1987 and served as RCT’s CEO from its founding in 1987 to May 2005. In June 2005, he became Chairman of the Board, a position he held until his resignation in May. He is succeeded by John W. McIntyre, who previously served as RCT’s Vice Chairman from 2013 to May 2018. Mr. McIntyre added, “Millions of individuals have benefited from technologies funded and developed by RCT. Dr. Munsinger has been the guiding force behind the company’s many successes. RCT is forever grateful to him for his vision and leadership in developing the company’s reputation and capabilities over the past 31 years. Through RCT, Dr. Munsinger has established an enduring legacy in Tucson and the world. All of us at RCT are proud to be part of this legacy.”
About Research Corporation Technologies
Research Corporation Technologies, Inc. (RCT) is a Tucson, Arizona-based technology investment and management company that provides early-stage funding and development for promising biomedical companies and technologies. RCT has assets of more than $450 million to advance technology development through flexible, long-term investment options. RCT focuses on technology investments with origins from universities and research institutions worldwide. To learn more about RCT, see www.rctech.com.